FAQs Your Top BPC-157 Dosage Questions Answered Still have questions
This effect generally resolves by reducing the dose or adjusting administration timing earlier in the evening
Contraindications Pregnancy and breastfeeding represent absolute contraindications due to BPC-157s cell proliferative effects and lack of safety data in these populations
Our FOXO4-Dri 10mg is synthesized using advanced solid-phase peptide synthesis (SPPS) techniques, ensuring that every milligram meets the rigorous demands of modern laboratory environments
If nausea is your worst symptom, our Anti-Nausea Boost provides additional medication to settle your stomach
Wolverine stack protocol for shoulder injuries Based on reported protocols in the literature: BPC-157 component: 250 to 500 mcg daily, split into morning and evening doses Subcutaneous injection, ideally near the shoulder (periarticular) with medical guidance, or abdomen/thigh for systemic delivery TB-500 component: 750 to 2000 mcg twice weekly during loading phase (first two to four weeks) 500 to 1000 mcg twice weekly during maintenance phase Subcutaneous injection at any standard site Combined cycle: Loading phase: four weeks Maintenance: four to eight additional weeks Total cycle: eight to twelve weeks Rest period: four to six weeks between cycles if needed For precise dosing calculations, the peptide calculator helps determine exact amounts based on your reconstitution volume and vial size